Elsevier

Experimental Neurology

Volume 209, Issue 1, January 2008, Pages 288-291
Experimental Neurology

Short Communication
Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease

https://doi.org/10.1016/j.expneurol.2007.09.012Get rights and content

Abstract

Juvenile Batten disease, caused by mutations in the CLN3 gene, is a fatal, incurable neurodegenerative disorder in children. The Cln3-loss-of-function (Cln3Δex1–6) mouse model of the disease exhibits many characteristic pathological features of the human disorder including a deficit in motor skills. Our recent findings [Kovács, A.D., Weimer, J.M., Pearce, D.A., 2006. Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease. Neurobiol. Dis. 22, 575–585] suggested that the neurological deficit in the Cln3Δex1–6 mouse model of the disease might result from an abnormally increased AMPA receptor activity in the cerebellum. Therefore, we tested if administration of low doses of an AMPA receptor antagonist, that attenuate AMPA receptor function but avoid a toxic, complete blockade of the receptor, have beneficial effects in Cln3Δex1–6 mice. Here we show that attenuation of AMPA receptor activity by a single intraperitoneal injection of the non-competitive AMPA antagonist, EGIS-8332 (1 mg/kg), significantly improves the motor skills of Cln3Δex1–6 mice. Our results provide a new, promising therapeutic approach for juvenile Batten disease.

Section snippets

Acknowledgments

This work was funded in part by National Institutes of Health (NIH) R01 NS44310 and the Luke and Rachel Batten Foundation.

Cited by (57)

  • The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research

    2020, Biochimica et Biophysica Acta - Molecular Basis of Disease
  • Cellular models of Batten disease

    2020, Biochimica et Biophysica Acta - Molecular Basis of Disease
  • Lysosomal Storage Disorders

    2020, Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics: Metabolic Disorders
  • Chronic hyperammonemia alters in opposite ways membrane expression of GluA1 and GluA2 AMPA receptor subunits in cerebellum. Molecular mechanisms involved

    2018, Biochimica et Biophysica Acta - Molecular Basis of Disease
    Citation Excerpt :

    AMPA receptors (AMPARs) are ionotropic glutamate receptors that mediate fast synaptic transmission in the central nervous system and modulate cognitive and motor function [1–9].

View all citing articles on Scopus
View full text